Apg Asset Management N.V. Innoviva, Inc. Transaction History

Apg Asset Management N.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $4.49 Million - $6.59 Million	-328,300 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$13.96 - $18.26 $3.91 Million - $5.11 Million	279,800 Added 576.91%	328,300 $5.01 Million
Q3 2018 Nov 09, 2018	BUY	$13.63 - $15.7 $661,055 - $761,450	48,500 New	48,500 $636,000
Q4 2017 Jan 24, 2018	SELL	$11.73 - $14.75 $335,478 - $421,850	-28,600 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$12.06 - $14.12 $344,916 - $403,832	28,600	28,600 $404,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.